Angiotensin 1-7 (Ang-(1-7)) is a major active component of the renin-angiotensin system (RAS), produced from cleavage of Ang II by angiotensin-converting-enzyme type 2 (ACE2). Angiotensin 1-7 inhibits purified canine ACE activity (IC50=0.65 μM). Angiotensin 1-7 acts as a local synergistic modulator of kinin-induced vasodilation by inhibiting ACE and releasing nitric oxide. Angiotensin 1-7 blocks Ang II-induced smooth muscle cell proliferation and hypertrophy and shows antiangiogenic and growth-inhibitory effects on the endothelium. Angiotensin 1-7 shows anti-inflammatory activity.
CAT No: R1805
CAS No:51833-78-4
Synonyms/Alias:Angiotensin (1-7);51833-78-4;angiotensin 1-7;ASP-ARG-VAL-TYR-ILE-HIS-PRO;TXA127;Angiotensin i (1-7);angiotensin-(1-7);Angiotensin II (1-7) heptapeptide;angiotensin II (1-7);8-Des-phe-angiotensin II;Ang-(1-7);TXA-127;Human angiotensin-(1-7);1-7-Human angiotensin II;Sh-heptapeptide-13;Bf-angiotensin 1-7;TXA 127;IJ3FUK8MOF;ang 1-7;MFCD00153513;39386-80-6;Angiotensin peptide (1-7);5-ile-angiotensin-(1-7);Human angiotensin ii (1-7);CHEBI:55438;Ile(5)-angiotensin II (1-7);Angiotensin II, 5-L-isoleucine-8-de-L-phenylalanine-;Angiotensin I/II (1-7) trifluoroacetate salt;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid;Angiotensin (1-7) xTFA salt;L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline;L-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline;(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid;angiotensin-I (1-7);UNII-IJ3FUK8MOF;Angiotensin, Canine, Rat;Ang I (1-7);Angiotensin II, des-phe(8)-;(2S)-1-((2S)-2-(((2S,3S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-amino-4-hydroxy-4-oxobutanoyl)amino)-5-(diaminomethylideneamino)pentanoyl)amino)-3-methylbutanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-methylpentanoyl)amino)-3-(3H-imidazol-4-yl)propanoyl)pyrrolidine-2-carboxylic acid;Ang-1-7 acetate;Angiotensin(1-7);DRVYIHP;Angiotensin II, des-phenylalanine(8)-;Angiotensin i/ii(1-7);Talfirastide (USAN/INN);GTPL582;Ang(1-7);GTPL5578;Therapeutic Angiotensin-(1-7);ANGIOTENSIN 1-7 ACETATE;CHEMBL3545347;SCHEMBL15926158;SCHEMBL25354851;BDBM85556;PVHLMTREZMEJCG-GDTLVBQBSA-N;[125I]ang-(1-7);GLXC-15146;ANGIOTENSIN 1-7 [WHO-DD];EX-A7295;SH-HEPTAPEPTIDE-13 [INCI];TXA127; Ang-(1-7);AKOS024456667;AKOS040759110;CS-3413;DB11720;Angiotensin (1-7) acetate salt hydrate;Angiotensin II, 8-de-L-phenylalanine-;NCGC00167219-01;AS-76407;DA-70861;FA108515;HY-12403;NS00073118;1-7-ANGIOTENSIN II, 5-L-ISOLEUCINE-;D12942;F85068;[125I]angiotensin-(1-7) (human, mouse, rat);BRD-K36040345-001-01-1;BRD-K36040345-001-02-9;Q27074464;(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-AMINO-3-CARBOXYPROPANAMIDO]-5-CARBAMIMIDAMIDOPENTANAMIDO]-3-METHYLBUTANAMIDO]-3-(4-HYDROXYPHENYL)PROPANAMIDO]-3-METHYLPENTANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID;(S)-1-((6S,9S,12S,15S,18S)-18-((1H-imidazol-4-yl)methyl)-1-amino-6-((S)-2-amino-3-carboxypropanamido)-15-sec-butyl-12-(4-hydroxybenzyl)-1-imino-9-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecane)pyrrolidine-2-carboxylic acid;
Angiotensin (1-7) is a bioactive heptapeptide derived from the renin-angiotensin system, recognized for its distinct physiological and biochemical properties compared to other angiotensin peptides. Structurally, it is formed by the enzymatic cleavage of angiotensin I or angiotensin II and is characterized by its unique C-terminal sequence, which confers specialized receptor interactions. The peptide plays a significant role in modulating vascular tone, cellular signaling, and tissue homeostasis, making it a subject of considerable interest in fundamental and applied peptide research. Its actions are primarily mediated through the Mas receptor, distinguishing its functional profile from the classical angiotensin II pathway and positioning it as a key molecule in the study of peptide-mediated regulatory mechanisms.
Peptide signaling research: Angiotensin (1-7) serves as a critical tool for investigating the molecular mechanisms governing peptide-mediated signaling within the renin-angiotensin system. By selectively activating the Mas receptor, it enables researchers to delineate the downstream signaling cascades distinct from those triggered by angiotensin II. The peptide's unique receptor specificity allows for the dissection of non-classical angiotensin pathways, providing valuable insights into the regulatory networks that govern vascular tone, cell proliferation, and tissue remodeling. Utilizing this heptapeptide in in vitro and ex vivo systems facilitates the exploration of peptide-receptor interactions and their physiological consequences at the cellular and molecular levels.
Vascular function studies: Researchers employ Angiotensin (1-7) to assess its modulatory effects on vascular smooth muscle cells and endothelial function. Its ability to counterbalance the vasoconstrictive actions of angiotensin II through vasodilatory and anti-proliferative mechanisms makes it an essential reagent for studies focused on vascular reactivity, endothelial signaling, and nitric oxide production. Experimental protocols often utilize the peptide to probe the interplay between different angiotensin-derived peptides in regulating blood vessel tone, permeability, and cellular communication within the vascular wall, thereby advancing the understanding of homeostatic control in cardiovascular biology.
Peptide synthesis and analytical method development: The defined sequence and functional stability of Angiotensin (1-7) make it a valuable reference standard in peptide synthesis, purification, and analytical validation workflows. Synthetic applications include optimization of solid-phase peptide synthesis protocols, assessment of peptide purity through chromatographic techniques, and the development of mass spectrometry-based assays for peptide quantification. Its use as a calibration standard or positive control enhances the reliability and reproducibility of peptide-focused analytical methods, supporting both basic research and quality assurance in peptide chemistry laboratories.
Receptor pharmacology assays: Angiotensin (1-7) is widely utilized in receptor binding and functional assays to characterize the pharmacological properties of the Mas receptor and related signaling components. By serving as a selective agonist, it provides a basis for evaluating ligand-receptor affinity, receptor activation profiles, and downstream effector responses. These assays are instrumental in screening for novel modulators of the Mas receptor pathway, mapping receptor distribution in various tissues, and understanding receptor-mediated cross-talk with other peptide systems. The peptide's application in these contexts supports the development of new molecular probes and the refinement of receptor-targeted assay platforms.
Cellular and tissue model systems: In vitro and ex vivo models frequently incorporate Angiotensin (1-7) to investigate its regulatory roles across diverse cell types and tissue preparations. Its influence on processes such as apoptosis, oxidative stress, and extracellular matrix remodeling is of particular interest to researchers studying tissue homeostasis and pathophysiological adaptation. By modulating signaling pathways in cultured cells or organotypic slices, the peptide enables detailed analysis of cell-specific responses, intercellular communication, and adaptive mechanisms under controlled experimental conditions. These investigations contribute to a deeper understanding of peptide function in complex biological systems and support the design of targeted experimental strategies in peptide biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.